DK3712152T3 - 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer - Google Patents
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer Download PDFInfo
- Publication number
- DK3712152T3 DK3712152T3 DK20171633.9T DK20171633T DK3712152T3 DK 3712152 T3 DK3712152 T3 DK 3712152T3 DK 20171633 T DK20171633 T DK 20171633T DK 3712152 T3 DK3712152 T3 DK 3712152T3
- Authority
- DK
- Denmark
- Prior art keywords
- chinase
- hexahydroimidazo
- janus
- imidazo
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1519381.6A GB201519381D0 (en) | 2015-11-03 | 2015-11-03 | Kinase inhibitors |
GB201606968 | 2016-04-21 | ||
EP16793973.5A EP3371184A1 (en) | 2015-11-03 | 2016-11-02 | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3712152T3 true DK3712152T3 (da) | 2021-03-22 |
Family
ID=57256356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK20171633.9T DK3712152T3 (da) | 2015-11-03 | 2016-11-02 | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer |
Country Status (8)
Country | Link |
---|---|
US (1) | US10851097B2 (da) |
EP (3) | EP3865481A1 (da) |
CA (1) | CA3037243A1 (da) |
DK (1) | DK3712152T3 (da) |
ES (1) | ES2864035T3 (da) |
PL (1) | PL3712152T3 (da) |
PT (1) | PT3712152T (da) |
WO (1) | WO2017077283A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10556901B2 (en) | 2015-11-03 | 2020-02-11 | Topivert Pharma Limited | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as Janus kinase inhibitors |
MX2018005446A (es) | 2015-11-03 | 2018-08-01 | Theravance Biopharma R&D Ip Llc | Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria. |
PT3592742T (pt) | 2017-03-09 | 2021-07-30 | Theravance Biopharma R&D Ip Llc | Inibidores de jak contendo uma amida heterocíclica com 4 membros |
AR111495A1 (es) | 2017-05-01 | 2019-07-17 | Theravance Biopharma R&D Ip Llc | Compuestos de imidazo-piperidina fusionada como inhibidores de jak |
EP3619208B1 (en) | 2017-05-01 | 2023-06-07 | Theravance Biopharma R&D IP, LLC | Crystalline forms of a jak inhibitor compound |
BR112019022665A2 (pt) | 2017-05-01 | 2020-05-19 | Theravance Biopharma R&D Ip Llc | métodos de tratamento usando um composto inibidor de jak |
US10392368B2 (en) | 2017-08-01 | 2019-08-27 | Theravance Biopharma R&D Ip, Llc | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors |
TWI791886B (zh) | 2018-09-04 | 2023-02-11 | 美商施萬生物製藥研發 Ip有限責任公司 | 作為jak抑制劑之二甲基胺基氮雜環丁烷醯胺 |
CA3108848A1 (en) | 2018-09-04 | 2020-03-12 | Theravance Biopharma R&D Ip, Llc | Process for preparing jak inhibitors and intermediates thereof |
US10836763B2 (en) | 2018-09-04 | 2020-11-17 | Theravance Biopharma R&D Ip, Llc | 5 to 7 membered heterocyclic amides as JAK inhibitors |
US10968222B2 (en) | 2018-10-29 | 2021-04-06 | Theravance Biopharma R&D Ip, Llc | 2-azabicyclo hexane JAK inhibitor compound |
WO2020154350A1 (en) * | 2019-01-23 | 2020-07-30 | Theravance Biopharma R&D Ip, Llc | Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors |
EP3932919B1 (en) | 2019-02-25 | 2024-06-26 | Henan Medinno Pharmaceutical Technology Co., Ltd. | Jak inhibitor compound and use thereof |
CN114075200A (zh) * | 2020-08-14 | 2022-02-22 | 河南迈英诺医药科技有限公司 | 用于治疗重症肺炎的jak抑制剂化合物 |
CN114075199A (zh) * | 2020-08-14 | 2022-02-22 | 河南迈英诺医药科技有限公司 | Jak抑制剂化合物及其用途 |
TW202144343A (zh) | 2020-03-02 | 2021-12-01 | 美商施萬生物製藥研發 Ip有限責任公司 | Jak抑制劑化合物之結晶水合物 |
CN115043844B (zh) * | 2021-06-21 | 2024-05-17 | 河南迈英诺医药科技有限公司 | Trk激酶抑制剂化合物及其用途 |
CN117343063A (zh) * | 2022-07-04 | 2024-01-05 | 河南迈英诺医药科技有限公司 | 作为trk抑制剂和/或ret抑制剂的化合物及其用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2523303T3 (es) | 2007-07-11 | 2014-11-24 | Pfizer Inc. | Composiciones farmacéuticas y procedimientos de tratamiento de trastornos del ojo seco |
US8575336B2 (en) * | 2011-07-27 | 2013-11-05 | Pfizer Limited | Indazoles |
FR2981917B1 (fr) | 2011-10-26 | 2013-11-15 | Cadorit Ag | Recipient pour emballer un premier fluide et un deuxieme fluide |
EP2864347B1 (en) | 2012-06-22 | 2020-10-28 | Mimetogen Pharmaceuticals, Inc. | Synthesis of beta-turn peptidomimetic cyclic compounds |
JP6663857B2 (ja) | 2014-05-14 | 2020-03-13 | ファイザー・インク | ピラゾロピリジンおよびピラゾロピリミジン |
EA032953B1 (ru) | 2015-05-28 | 2019-08-30 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Нафтиридиновые соединения в качестве ингибиторов jak киназы |
US10556901B2 (en) | 2015-11-03 | 2020-02-11 | Topivert Pharma Limited | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as Janus kinase inhibitors |
MX2018005446A (es) | 2015-11-03 | 2018-08-01 | Theravance Biopharma R&D Ip Llc | Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria. |
ME03757B (me) | 2015-11-24 | 2021-04-20 | Theravance Biopharma R&D Ip Llc | Prolekovi jaki inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti |
BR112018072168A2 (pt) | 2016-04-28 | 2019-02-12 | Theravance Biopharma R&D Ip, Llc | compostos derivados da pirimidina como inibidores da quinase jak |
-
2016
- 2016-11-02 PL PL20171633T patent/PL3712152T3/pl unknown
- 2016-11-02 PT PT201716339T patent/PT3712152T/pt unknown
- 2016-11-02 DK DK20171633.9T patent/DK3712152T3/da active
- 2016-11-02 EP EP21151168.8A patent/EP3865481A1/en not_active Withdrawn
- 2016-11-02 ES ES20171633T patent/ES2864035T3/es active Active
- 2016-11-02 CA CA3037243A patent/CA3037243A1/en not_active Abandoned
- 2016-11-02 US US15/772,861 patent/US10851097B2/en active Active
- 2016-11-02 EP EP16793973.5A patent/EP3371184A1/en not_active Withdrawn
- 2016-11-02 WO PCT/GB2016/053387 patent/WO2017077283A1/en active Application Filing
- 2016-11-02 EP EP20171633.9A patent/EP3712152B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2864035T3 (es) | 2021-10-13 |
EP3371184A1 (en) | 2018-09-12 |
EP3712152A1 (en) | 2020-09-23 |
PT3712152T (pt) | 2021-04-15 |
EP3712152B1 (en) | 2021-01-13 |
EP3865481A1 (en) | 2021-08-18 |
US20180319791A1 (en) | 2018-11-08 |
US10851097B2 (en) | 2020-12-01 |
CA3037243A1 (en) | 2017-05-11 |
PL3712152T3 (pl) | 2021-08-02 |
WO2017077283A1 (en) | 2017-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3712152T3 (da) | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer | |
DK3371185T3 (da) | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus-kinase-inhibitorer | |
DK3558990T3 (da) | Tetrahydroimidazo[4,5-c]pyridinderivater som pd-l1 internaliseringsinducere | |
HK1258857A1 (zh) | 作為lrrk2抑制劑的新穎咪唑並[4,5-c]喹啉和咪唑並[4,5- c][1,5]萘啶衍生物 | |
DK3523301T3 (da) | Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer | |
DK3523302T3 (da) | Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer | |
DK3322706T3 (da) | Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer | |
DK3194388T3 (da) | Imidazo[4,5-c]pyridin afledte ssao-inhibitorer | |
DK3466955T3 (da) | Fremgangsmåde til fremstilling af oxazol[4,5-b]pyridin og thiazol[4,5-b]pyridinderivater som irak4-hæmmere til behandling af cancer | |
CR20160449A (es) | Inhibidores de la jak1 para el tratamiento de síndromes mielodisplásicos | |
DK3478681T3 (da) | 1h-pyrazolo[4,3-b]pyridiner som pde1-inhibitorer | |
DK3237423T3 (da) | Thieno[2,3-c]pyrrol-4-on-derivater som erk-inhibitorer | |
DK2970260T3 (da) | Imidazo-[4,5-c]pyridin- og pyrrolo-[2,3-c]pyridinderivater som ssao-inhibitorer | |
DK3481827T3 (da) | Imidazo[1,2-a]pyridinderivater, fremgangsmåder til fremstilling og anvendelse deraf | |
HK1255804A1 (zh) | 作為雙重dyrk1/clk1抑制劑的新的咪唑並[4,5-b]吡啶衍生物 | |
IL269214B (en) | Novel imidazo[5,4-c]quinoline derivatives as lrrk2 inhibitors | |
SI2991983T1 (sl) | DERIVATI 2-FENIL ALI 2-HETARIL IMIDAZOL(1,2-a)PIRIDINA | |
DK3347356T3 (da) | Tricyclic forbundet pyridin-2-one-derivater og deres anvendelse som brd4-hæmmere | |
IL251166B (en) | Imidazo–[4,5–c]pyridine derivatives as inhibitors of ssao | |
DK3472160T3 (da) | Bicykliske pyridin-, pyrazin- og pyrimidinderivater som pi3k-beta-inhibitorer |